Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs.
[Lung abscess: Diagnosis and management].
Feki W, Ketata W, Bahloul N, Ayadi H, Yangui I, Kammoun S.
Rev Mal Respir. 2019 Jun;36(6):707-719. doi: 10.1016/j.rmr.2018.07.010. Epub 2019 Jun 13.
Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs.
Zhou F, Ma W, Li W, Ni H, Gao G, Chen X, Zhang J, Shi J.
BMC Cancer. 2018 Oct 23;18(1):1033. doi: 10.1186/s12885-018-4938-9.
Improved Diagnostic Criteria for Apical Hypertrophic Cardiomyopathy.
Hughes RK, Shiwani H, Rosmini S, Augusto JB, Burke L, Jiang Y, Pierce I, Joy G, Castelletti S, Orini M, Kellman P, Xue H, Lopes LR, Mohiddin S, Treibel T, Manisty C, Captur G, Davies R, Moon JC.
JACC Cardiovasc Imaging. 2024 May;17(5):501-512. doi: 10.1016/j.jcmg.2023.07.012. Epub 2023 Oct 11.
Aspergilloma.
Chakraborty RK, Gilotra TS, Tobin EH, Baradhi KM.
2024 Jan 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Cavity Wall Thickness in Solitary Cavitary Lung Adenocarcinomas Is a Prognostic Indicator.
Watanabe Y, Kusumoto M, Yoshida A, Shiraishi K, Suzuki K, Watanabe SI, Tsuta K.
Ann Thorac Surg. 2016 Dec;102(6):1863-1871. doi: 10.1016/j.athoracsur.2016.03.121. Epub 2016 Sep 20.
Solitary cavities of the lung: diagnostic implications of cavity wall thickness.
Woodring JH, Fried AM, Chuang VP.
AJR Am J Roentgenol. 1980 Dec;135(6):1269-71. doi: 10.2214/ajr.135.6.1269.
Right Ventricular Hypertrophy.
Bhattacharya PT, Shams P, Ellison MB.
2024 Mar 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
Vissing CR, Axelsson Raja A, Day SM, Russell MW, Zahka K, Lever HM, Pereira AC, Colan SD, Margossian R, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Soslow JH, Becker JR, Seidman CE, Lakdawala NK, Cirino AL, McMurray JJV, MacRae CA, Solomon SD, Bundgaard H, Orav EJ, Ho CY; Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Investigators.
JAMA Cardiol. 2023 Nov 1;8(11):1083-1088. doi: 10.1001/jamacardio.2023.2808.
Lateral cavity wall thickening as an early radiographic sign of mycetoma formation.
Sansom HE, Baque-Juston M, Wells AU, Hansell DM.
Eur Radiol. 2000;10(2):387-90. doi: 10.1007/s003300050061.
Ominous lung cavity "Tambourine sign".
Verma R, Bhalla AS, Goyal A, Jain D, Loganathan N, Guleria R.
World J Clin Cases. 2017 Apr 16;5(4):153-158. doi: 10.12998/wjcc.v5.i4.153.
